435 related articles for article (PubMed ID: 24291173)
1. Olmesartan protects against oxidative stress possibly through the Nrf2 signaling pathway and inhibits inflammation in daunorubicin-induced nephrotoxicity in rats.
Gounder VK; Arumugam S; Arozal W; Thandavarayan RA; Pitchaimani V; Harima M; Suzuki K; Nomoto M; Watanabe K
Int Immunopharmacol; 2014 Feb; 18(2):282-9. PubMed ID: 24291173
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions.
Arozal W; Watanabe K; Veeraveedu PT; Ma M; Thandavarayan RA; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
Toxicology; 2011 Jan; 279(1-3):91-9. PubMed ID: 20888384
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats.
Arozal W; Watanabe K; Veeraveedu PT; Thandavarayan RA; Harima M; Sukumaran V; Suzuki K; Tachikawa H; Kodama M; Aizawa Y
Free Radic Res; 2010 Nov; 44(11):1369-77. PubMed ID: 20815778
[TBL] [Abstract][Full Text] [Related]
4. Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation.
Karuppagounder V; Arumugam S; Thandavarayan RA; Pitchaimani V; Sreedhar R; Afrin R; Harima M; Suzuki H; Suzuki K; Nakamura M; Ueno K; Watanabe K
Int Immunopharmacol; 2015 Sep; 28(1):154-9. PubMed ID: 26072060
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats.
Arozal W; Watanabe K; Veeraveedu PT; Ma M; Thandavarayan RA; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
Toxicology; 2010; 274(1-3):18-26. PubMed ID: 20452391
[TBL] [Abstract][Full Text] [Related]
6. Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
Kim HJ; Sato T; Rodríguez-Iturbe B; Vaziri ND
J Pharmacol Exp Ther; 2011 Jun; 337(3):583-90. PubMed ID: 21357516
[TBL] [Abstract][Full Text] [Related]
7. Effect of telmisartan in limiting the cardiotoxic effect of daunorubicin in rats.
Arozal W; Watanabe K; Veeraveedu PT; Thandavarayan RA; Harima M; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
J Pharm Pharmacol; 2010 Dec; 62(12):1776-83. PubMed ID: 21054405
[TBL] [Abstract][Full Text] [Related]
8. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway.
Soetikno V; Sari FR; Lakshmanan AP; Arumugam S; Harima M; Suzuki K; Kawachi H; Watanabe K
Mol Nutr Food Res; 2013 Sep; 57(9):1649-59. PubMed ID: 23174956
[TBL] [Abstract][Full Text] [Related]
9. Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress.
Shimizu S; Saito M; Oiwa H; Ohmasa F; Tsounapi P; Oikawa R; Dimitriadis F; Martin DT; Satoh I; Kinoshita Y; Tomita S
Neurourol Urodyn; 2014 Mar; 33(3):350-7. PubMed ID: 23775684
[TBL] [Abstract][Full Text] [Related]
10. S-allylcysteine prevents cisplatin-induced nephrotoxicity and oxidative stress.
Gómez-Sierra T; Molina-Jijón E; Tapia E; Hernández-Pando R; García-Niño WR; Maldonado PD; Reyes JL; Barrera-Oviedo D; Torres I; Pedraza-Chaverri J
J Pharm Pharmacol; 2014 Sep; 66(9):1271-81. PubMed ID: 24779924
[TBL] [Abstract][Full Text] [Related]
11. Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats.
Kalayarasan S; Prabhu PN; Sriram N; Manikandan R; Arumugam M; Sudhandiran G
Eur J Pharmacol; 2009 Mar; 606(1-3):162-71. PubMed ID: 19374873
[TBL] [Abstract][Full Text] [Related]
12. Curcumin alleviates renal dysfunction and suppresses inflammation by shifting from M1 to M2 macrophage polarization in daunorubicin induced nephrotoxicity in rats.
Karuppagounder V; Arumugam S; Thandavarayan RA; Sreedhar R; Giridharan VV; Afrin R; Harima M; Miyashita S; Hara M; Suzuki K; Nakamura M; Ueno K; Watanabe K
Cytokine; 2016 Aug; 84():1-9. PubMed ID: 27203664
[TBL] [Abstract][Full Text] [Related]
13. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
[TBL] [Abstract][Full Text] [Related]
14. An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy.
Takahashi T; Konta T; Takasaki S; Ichikawa K; Takeishi Y; Kubota I
Clin Exp Nephrol; 2007 Sep; 11(3):202-208. PubMed ID: 17891346
[TBL] [Abstract][Full Text] [Related]
15. Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury.
Fouad AA; Qureshi HA; Al-Sultan AI; Yacoubi MT; Al-Melhim WN
Pharmacology; 2010; 85(3):158-67. PubMed ID: 20150754
[TBL] [Abstract][Full Text] [Related]
16. Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.
Sukumaran V; Veeraveedu PT; Gurusamy N; Lakshmanan AP; Yamaguchi K; Ma M; Suzuki K; Nagata M; Takagi R; Kodama M; Watanabe K
Mol Cell Endocrinol; 2012 Apr; 351(2):208-19. PubMed ID: 22200414
[TBL] [Abstract][Full Text] [Related]
17. Xin-Ji-Er-Kang ameliorates kidney injury following myocardial infarction by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats.
Lian FZ; Cheng P; Ruan CS; Ling XX; Wang XY; Pan M; Chen ML; Shen AZ; Gao S
Biomed Pharmacother; 2019 Sep; 117():109124. PubMed ID: 31228798
[TBL] [Abstract][Full Text] [Related]
18. Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice.
Lakshmanan AP; Thandavarayan RA; Watanabe K; Sari FR; Meilei H; Giridharan VV; Sukumaran V; Soetikno V; Arumugam S; Suzuki K; Kodama M
Mol Cell Endocrinol; 2012 Jan; 348(1):104-11. PubMed ID: 21827824
[TBL] [Abstract][Full Text] [Related]
19. Fimasartan, a Novel Angiotensin-Receptor Blocker, Protects against Renal Inflammation and Fibrosis in Mice with Unilateral Ureteral Obstruction: the Possible Role of Nrf2.
Kim S; Kim SJ; Yoon HE; Chung S; Choi BS; Park CW; Shin SJ
Int J Med Sci; 2015; 12(11):891-904. PubMed ID: 26640409
[TBL] [Abstract][Full Text] [Related]
20. Nephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stress.
Sultana S; Verma K; Khan R
J Pharm Pharmacol; 2012 Jun; 64(6):872-81. PubMed ID: 22571266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
